Cargando…

P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients

Detalles Bibliográficos
Autores principales: Mitova, V., Gavrilov, I., Gornev, R., Plachkova, M.D., Pakataridis, P., Atanasov, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013703/
http://dx.doi.org/10.1016/S0960-9776(23)00377-6
_version_ 1784906831755214848
author Mitova, V.
Gavrilov, I.
Gornev, R.
Plachkova, M.D.
Pakataridis, P.
Atanasov, T.
author_facet Mitova, V.
Gavrilov, I.
Gornev, R.
Plachkova, M.D.
Pakataridis, P.
Atanasov, T.
author_sort Mitova, V.
collection PubMed
description
format Online
Article
Text
id pubmed-10013703
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-100137032023-03-15 P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients Mitova, V. Gavrilov, I. Gornev, R. Plachkova, M.D. Pakataridis, P. Atanasov, T. Breast Poster Abstracts Elsevier Ltd. 2023-04 2023-03-14 /pmc/articles/PMC10013703/ http://dx.doi.org/10.1016/S0960-9776(23)00377-6 Text en Copyright © 2023 Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Abstracts
Mitova, V.
Gavrilov, I.
Gornev, R.
Plachkova, M.D.
Pakataridis, P.
Atanasov, T.
P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients
title P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients
title_full P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients
title_fullStr P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients
title_full_unstemmed P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients
title_short P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients
title_sort p259 immune-mediated implications of sars-cov-2 in breast cancer patients
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013703/
http://dx.doi.org/10.1016/S0960-9776(23)00377-6
work_keys_str_mv AT mitovav p259immunemediatedimplicationsofsarscov2inbreastcancerpatients
AT gavrilovi p259immunemediatedimplicationsofsarscov2inbreastcancerpatients
AT gornevr p259immunemediatedimplicationsofsarscov2inbreastcancerpatients
AT plachkovamd p259immunemediatedimplicationsofsarscov2inbreastcancerpatients
AT pakataridisp p259immunemediatedimplicationsofsarscov2inbreastcancerpatients
AT atanasovt p259immunemediatedimplicationsofsarscov2inbreastcancerpatients